NO20060803L - Orodispersibel farmasoytisk sammensetning av en antitrombotisk forbindelse - Google Patents

Orodispersibel farmasoytisk sammensetning av en antitrombotisk forbindelse

Info

Publication number
NO20060803L
NO20060803L NO20060803A NO20060803A NO20060803L NO 20060803 L NO20060803 L NO 20060803L NO 20060803 A NO20060803 A NO 20060803A NO 20060803 A NO20060803 A NO 20060803A NO 20060803 L NO20060803 L NO 20060803L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
compound
orodispersible pharmaceutical
antithrombotic compound
orodispersible
Prior art date
Application number
NO20060803A
Other languages
English (en)
Norwegian (no)
Inventor
Herve Rolland
Patrick Wuthrich
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20060803L publication Critical patent/NO20060803L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20060803A 2003-07-18 2006-02-17 Orodispersibel farmasoytisk sammensetning av en antitrombotisk forbindelse NO20060803L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308780A FR2857593B1 (fr) 2003-07-18 2003-07-18 Composition pharmaceutique orodispersible d'un compose antithrombotique
PCT/FR2004/001866 WO2005009428A2 (fr) 2003-07-18 2004-07-16 Composition pharmaceutique orodispersible d'un compose antithrombotique

Publications (1)

Publication Number Publication Date
NO20060803L true NO20060803L (no) 2006-02-17

Family

ID=33548240

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060803A NO20060803L (no) 2003-07-18 2006-02-17 Orodispersibel farmasoytisk sammensetning av en antitrombotisk forbindelse

Country Status (27)

Country Link
US (1) US20060167100A1 (de)
EP (1) EP1646373B1 (de)
JP (1) JP2006528160A (de)
KR (1) KR100762598B1 (de)
CN (1) CN100544709C (de)
AR (1) AR045724A1 (de)
AT (1) ATE409032T1 (de)
AU (1) AU2004258713B2 (de)
BR (1) BRPI0412706A (de)
CA (1) CA2532608A1 (de)
DE (1) DE602004016751D1 (de)
DK (1) DK1646373T3 (de)
EA (1) EA010372B1 (de)
ES (1) ES2314440T3 (de)
FR (1) FR2857593B1 (de)
GE (1) GEP20094649B (de)
HR (1) HRP20080521T3 (de)
MA (1) MA27891A1 (de)
MX (1) MXPA06000712A (de)
MY (1) MY138799A (de)
NO (1) NO20060803L (de)
PL (1) PL1646373T3 (de)
PT (1) PT1646373E (de)
SI (1) SI1646373T1 (de)
UA (1) UA79567C2 (de)
WO (1) WO2005009428A2 (de)
ZA (1) ZA200600241B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2899473B1 (fr) * 2006-04-07 2008-06-13 Servier Lab Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires
WO2008140520A1 (en) 2007-05-11 2008-11-20 Otis Elevator Company Elevator load bearing assembly having an initial factor of safety based upon a desired life of service
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
US8307129B2 (en) * 2008-01-14 2012-11-06 International Business Machines Corporation Methods and computer program products for swapping synchronous replication secondaries from a subchannel set other than zero to subchannel set zero using dynamic I/O
US7761610B2 (en) * 2008-01-25 2010-07-20 International Business Machines Corporation Methods and computer program products for defining synchronous replication devices in a subchannel set other than subchannel set zero
US8516173B2 (en) * 2008-07-28 2013-08-20 International Business Machines Corporation Swapping PPRC secondaries from a subchannel set other than zero to subchannel set zero using control block field manipulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6171616B1 (en) * 1998-04-13 2001-01-09 Shin-Etsu Chemical Co., Ltd. Solid preparation and a method of manufacturing it
EP1175899B1 (de) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granulat bestehend aus Stärke und Laktose
KR200250082Y1 (ko) * 2001-05-15 2001-11-16 포스텍전자주식회사 힌지 유니트

Also Published As

Publication number Publication date
CN100544709C (zh) 2009-09-30
MY138799A (en) 2009-07-31
CA2532608A1 (fr) 2005-02-03
MXPA06000712A (es) 2006-04-11
EA200600173A1 (ru) 2006-08-25
JP2006528160A (ja) 2006-12-14
AU2004258713A1 (en) 2005-02-03
ES2314440T3 (es) 2009-03-16
HRP20080521T3 (en) 2009-01-31
EP1646373A2 (de) 2006-04-19
US20060167100A1 (en) 2006-07-27
ZA200600241B (en) 2007-04-25
DE602004016751D1 (de) 2008-11-06
KR20060031688A (ko) 2006-04-12
GEP20094649B (en) 2009-03-25
EP1646373B1 (de) 2008-09-24
SI1646373T1 (sl) 2009-02-28
DK1646373T3 (da) 2008-12-15
MA27891A1 (fr) 2006-05-02
WO2005009428A3 (fr) 2005-04-07
PL1646373T3 (pl) 2009-02-27
AU2004258713B2 (en) 2007-07-12
ATE409032T1 (de) 2008-10-15
FR2857593B1 (fr) 2005-10-14
PT1646373E (pt) 2008-11-13
AR045724A1 (es) 2005-11-09
FR2857593A1 (fr) 2005-01-21
KR100762598B1 (ko) 2007-10-04
UA79567C2 (en) 2007-06-25
HK1094152A1 (zh) 2007-03-23
CN1819823A (zh) 2006-08-16
EA010372B1 (ru) 2008-08-29
WO2005009428A2 (fr) 2005-02-03
BRPI0412706A (pt) 2006-09-26

Similar Documents

Publication Publication Date Title
NO20031024D0 (no) Bicykliske pyrrolyl amider som glukogen fosforylase inhibitorer
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
WO2003048081A3 (en) Glycinamides as factor xa inhibitors
DE69920757D1 (de) Immunsuppressive wirkungen von pteridinderivaten
WO2006086562A3 (en) Phenylazetidinone derivatives
IS7306A (is) Lyfjasamsetningar taxanafleiðna, virkar eftir inntöku um munn, og sem eru með aukna líffræðilega virkni
NO20041452L (no) 17-beta-hydroksysteroid-dehydrogenase type 3-inhibitorer for behandling av androgenavhengige sykdommer.
EA200400928A1 (ru) Диспергируемая во рту фармацевтическая композиция агомелатина
WO2003047520A3 (en) SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
WO2003057145A3 (en) SUBSTITUTED 4,9-DIHYDROCYCLOPENTA[imn]PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
AU2002358082A1 (en) Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
TW200503703A (en) Pharmaceutical compositions
AR038206A1 (es) Composicion farmaceutica dispersable oralmente de ivabradina
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
MXPA06000712A (es) Composicion farmaceutica orodispersable de un compuesto antitrombotico.
WO2004026319A3 (en) Pharmaceutical compositions increasing camp useful for the treatment of cancers
ATE328595T1 (de) Carvedilolpolymorph
EP3040081A3 (de) Verwendung von protein-kinase-n beta
CL2003002295A1 (es) Derivados de bencenosulfonil-carbamoil-gamma-aminopropil sustituidos de 9-deoxo-9-dihidro-9a-aza-9a-homoeritromicina a y 5-o-desosaminil-9-deoxo-9-dihidro-9a-aza-9a-homoeritronolida a, composicion farmaceutica, procedimiento de preparacion, utiles pa
WO2006004903A3 (en) 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
NO20034998D0 (no) Citalopram til behandling av forhöyet blodtrykk
WO2004022657A8 (de) Verstärkung der resorption von substanzen über die haut und schleimhaut
WO2007052167A3 (en) Stable composition for a pharmaceutical formulation containing olanzapine
AR038208A1 (es) Composicion farmaceutica dispersable oralmente de mitiglinida

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application